Institute for Behavioral Research, University of Georgia, Athens, GA 30602-2401, USA.
J Subst Abuse Treat. 2012 Jan;42(1):16-24. doi: 10.1016/j.jsat.2011.06.009. Epub 2011 Aug 9.
Identifying facilitators of more rapid buprenorphine adoption may increase access to this effective treatment for opioid dependence. Using a diffusion of innovations theoretical framework, we examine the extent to which programs' interorganizational institutional and resource-based linkages predict the likelihood of being an earlier adopter, later adopter, or nonadopter of buprenorphine. Data were derived from face-to-face interviews with administrators of 345 privately funded substance abuse treatment programs in 2007-2008. Results of multinomial logistic regression models show that interorganizational and resource linkages were associated with timing of adoption. Programs reporting membership in provider associations were more likely to be earlier adopters of buprenorphine. Programs that relied more on resource linkages, such as detailing activities by pharmaceutical companies and the National Institute on Drug Abuse website, were more likely to be earlier adopters of buprenorphine. These findings suggest that institutional and resource-based interorganizational linkages may expose programs to effective treatments, thereby facilitating more rapid and sustained adoption of innovative treatment techniques.
确定能够促进丁丙诺啡更快采用的因素可能会增加阿片类药物依赖的有效治疗方法的可及性。本研究使用创新扩散理论框架，考察了组织间制度和资源联系在多大程度上预测了丁丙诺啡的早期采用、后期采用或不采用的可能性。数据来自于 2007-2008 年对 345 个私人资助的药物滥用治疗项目的管理人员进行的面对面访谈。多变量逻辑回归模型的结果表明，组织间和资源联系与采用的时间有关。报告参加提供者协会的项目更有可能成为丁丙诺啡的早期采用者。更多地依赖资源联系的项目，如制药公司的详细活动和国家药物滥用研究所网站，更有可能成为丁丙诺啡的早期采用者。这些发现表明，机构和基于资源的组织间联系可以使项目接触到有效的治疗方法，从而促进创新治疗技术更快、更持续地采用。
